ライフサイエンスコーパス: zygomycosis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 r optimizing outcomes in SOT recipients with zygomycosis.

2 = .002) was associated with a lower risk of zygomycosis.

3 d nomenclature of Zygomycota and the disease zygomycosis.

4 genic flies partially restored resistance to zygomycosis.

5 1 of 1 with cryptococcosis, and 1 of 2 with zygomycosis.

6 ole appears to be effective for treatment of zygomycosis.

7 e only factors that favored the diagnosis of zygomycosis.

8 ere found to be independent risk factors for zygomycosis.

9 k factor for the development of disseminated zygomycosis.

10 mophthoramycosis" are more appropriate than "zygomycosis."

11 Rhizopus oryzae is the most common cause of zygomycosis, a life-threatening infection that usually o

12 Between patients with zygomycosis (after excluding 6 patients with mixed mold

13 s that mediate host-pathogen interactions in zygomycosis and establish D. melanogaster as a promising

14 The risks identified for zygomycosis and for disseminated disease, including thos

15 tly developed paranasal and gastrointestinal zygomycosis and required surgical debridement and a prol

16 early, although pulmonary aspergillosis and zygomycosis are portentous ailments unless surgical rese

17 d other mold pathogens, such as Fusarium and zygomycosis, are assuming greater prominence and may be

18 SOT recipients with zygomycosis as per the European Organization for Researc

19 d strains in Drosophila and murine models of zygomycosis by assessment of survival curves, pulmonary

20 A case of primary cutaneous zygomycosis caused by Mucor circinelloides is described.

21 Sinus-orbital zygomycosis caused by Rhizomucor pusillus in a patient w

22 ting the 28S rRNA gene, for the diagnosis of zygomycosis caused by the most common, clinically signif

23 d disease (OR, 5.48; P = .021) and developed zygomycosis earlier after transplantation than did other

24 Nearly all patients with zygomycosis either had leukemia (n = 14) or were allogen

25 her mold infections (Fusarium, scedosporium, zygomycosis, etc.), those with candidemia, and control p

26 ainst IFIs including invasive aspergillosis, zygomycosis, fusariosis, and cryptococcosis in SOT recip

27 ed prospective surveillance of patients with zygomycosis (group A; n = 27) and compared them with con

28 t revision of original definition, the name "zygomycosis," however, has more often been used as a syn

29 This case report describes craniofacial zygomycosis in a 24-year-old male with Hodgkin's disease

30 We report a case of rhino-orbital zygomycosis in a 43-year-old male with well-controlled d

31 Anecdotal evidence suggests a rise in zygomycosis in association with voriconazole (VRC) use i

32 Apophysomyces elegans, an emerging cause of zygomycosis in immunocompetent hosts.

33 al disease is a significant manifestation of zygomycosis in solid organ transplant (SOT) recipients.

34 solid organ transplant (SOT) recipients with zygomycosis in the era of modern immunosuppressive and n

35 0 SOT recipients with rhino-orbital-cerebral zygomycosis, including 13 in our cohort and 77 in the li

36 Zygomycosis is an emerging frequently fatal opportunisti

37 A characteristic hallmark of zygomycosis is angioinvasion by the fungus, resulting in

38 Breakthrough zygomycosis is increasingly observed among patients at h

39 We developed a zygomycosis model by injecting Drosophila melanogaster f

40 pothesis, using 2 phylogenetically disparate zygomycosis models.

41 Rhino-orbital-cerebral zygomycosis, particularly CNS disease, is associated wit

42 ally applicable models of invasive pulmonary zygomycosis served as surrogates of human infections, fa

43 Zygomycosis should be considered in immunosuppressed pat

44 iorgan failure, bacteremia, and disseminated zygomycosis, the patient survived and had a good neurolo

45 Because the nomenclature of the disease zygomycosis was based on the phylum Zygomycota (Zygomyce

46 Zygomycosis was originally described as a convenient and

47 d case-controlled study, SOT recipients with zygomycosis were prospectively studied.

48 .033) were associated with a higher risk of zygomycosis, whereas tacrolimus (OR, 0.23; P = .002) was

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。